Digital therapists get stressed too, study finds
And when chatbots get stressed out, they are less likely to be useful in therapeutic settings with people. The bot’s anxiety ...
Roche signs $5.3 billion deal with Danish obesity drugmaker, Novo Nordisk stock slides 4%
Roche (RHHBY) is increasing its investment into the obesity space with an up to $5.3 billion deal with Danish drugmaker Zealand Pharma (ZLDPF), the companies announced Wednesday. The deal would give ...
Roche signs $5.3 billion deal with Danish obesity drugmaker, Novo stock slides 4%
Roche (RHHBY) is increasing its investment into the obesity space with an up to $5.3 billion deal with Danish drugmaker ...
VERZENIO's Market Potential Soars As Demand For CDK4/6 Inhibitors Grows Delveinsight
As VERZENIO gains traction in early-stage treatments and broadens its approved uses, its revenue is expected to keep growing. While the globa ...
Medscape4d
DVT Management: Is Stopping Anticoagulation Too Risky?
ECIM 2025 saw a heated discussion on whether anticoagulation in DVT should be treated like a chronic condition, as new ...
Pharmaceutical Technology on MSN6d
Viking strikes $150m deal to secure supply of obesity drug
Viking Therapeutics has inked a $150m multi-year manufacturing deal with CordenPharma to secure the future supply of its ...
Irish Examiner on MSN5d
Irish-US trade 'a two-way street', says AmCham report
Report shows 970 US companies employ 210,000 people in Ireland but notes Irish companies support 200,000 jobs across the US ...
FMIBlog4d
Global Acute Migraine Treatment Market Poised to Reach USD 4,194.1 Million by 2034 Amid Growing Awareness and Diagnosis | FMI
The global market for acute migraine treatment is on a steady growth trajectory, with sales expected to rise from USD 2,700.7 million in 2024 to USD 4,194.1 million by 2034, reflecting a CAGR of 4.5% ...